UBVCX | VSIAX | UBVCX / VSIAX | |
Total Expense Ratio | 1.74 | 0.07 | 2,486% |
Annual Report Gross Expense Ratio | 1.86 | 0.07 | 2,657% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 4.441 | 6.707 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.1B | 59.2B | 17% |
Annual Yield % from dividends | 1.17 | 1.97 | 59% |
Returns for 1 year | 2.80 | 10.22 | 27% |
Returns for 3 years | 11.56 | 36.67 | 32% |
Returns for 5 years | 82.25 | 86.42 | 95% |
Returns for 10 years | 54.59 | 117.84 | 46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 70.99 | 0.72 | +1.03% |
Invesco Biotechnology & Genome ETF | |||
IWC | 143.42 | 0.60 | +0.42% |
iShares Micro-Cap ETF | |||
LIAX | 248.44 | N/A | N/A |
LifeX 2063 Infl-Prt Longevity Inc ETF | |||
RPHS | 10.82 | -0.02 | -0.22% |
Regents Park Hedged Market Strategy ETF | |||
PLTY | 59.85 | -1.03 | -1.69% |
YieldMax PLTR Option Income Strategy ETF |